Precision BioSciences
DTIL
63 hedge funds and large institutions have $291M invested in Precision BioSciences in 2019 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 17 increasing their positions, 6 reducing their positions, and 16 closing their positions.
183% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 6
81% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 16
26% more funds holding
Funds holding: 50 → 63 (+13)
0.11% more ownership
Funds ownership: 1.35% → 1.46% (+0.11%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
18% less capital invested
Capital invested by funds: $357M → $291M (-$65.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$13M |
| 2 |
BlackRock
New York
|
+$7.13M |
| 3 |
DP
DSAM Partners
London,
United Kingdom
|
+$6.93M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$4.74M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.72M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$8.97M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$4.19M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$3.15M |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$3.14M |
| 5 |
Millennium Management
New York
|
-$3.08M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ECM
76
ExodusPoint Capital Management
New York
| – | -$215K | -400 | Closed |
|
77
SG Americas Securities
New York
| – | -$144K | -267 | Closed |
|
|
KC
78
KCL Capital
New York
| – | -$18K | -33 | Closed |
|
|
FIA
79
FNY Investment Advisers
New York
| – | -$2K | -5 | Closed |
|
DTIL Hedge Fund Activity: Q2 2019 in Review
63 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q2 2019, worth a combined $291M — down 18% from $357M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new DTIL positions and 16 closed out — a net gain of 13 holders — while 17 added to existing stakes and 6 trimmed.
The largest buyer was Franklin Resources, adding an estimated $13M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $8.97M sold.
- 63 institutional investors held Precision BioSciences (DTIL) as of Q2 2019, up from 50 in Q1 2019.
- Funds reported $291M of Precision BioSciences stock for Q2 2019, down 18% quarter-over-quarter.
- 29 funds opened new Precision BioSciences positions in Q2 2019 and 16 closed out, a net change of +13 holders.
- The largest Precision BioSciences buyer in Q2 2019 was Franklin Resources, an estimated $13M added.
- The largest Precision BioSciences seller in Q2 2019 was Janus Henderson Group, an estimated $8.97M sold.
Based on aggregated 13F filings for Q2 2019.